Tag: high-grade serous carcinoma

A single-cell transcriptomics study reveals that conserved fallopian tube epithelial programs drive chemoresistance and treatment response heterogeneity in ovarian high-grade ...

A phase 2 trial found that adding immunotherapy to chemotherapy did not improve the primary efficacy endpoint in advanced ovarian ...

A case report describes a 60-year-old woman with Müllerian-type high-grade serous carcinoma confined to the pleura, with no primary tumor ...

A new review explains how regulatory T cells are co-opted by ovarian tumors to suppress immunity, and how precision therapies ...

An analysis of 219 epithelial ovarian cancers found that HER2 protein expression and gene amplification varied by tumor subtype, while ...

A retrospective single-center cohort of 128 patients associated frontline bevacizumab with longer overall survival in advanced ovarian cancer, while clear ...

A case report in Oncoscience describes high-grade serous ovarian carcinoma diagnosed at ten weeks of gestation, illustrating the diagnostic and ...

In a groundbreaking advancement in ovarian cancer research, scientists have uncovered a critical mechanism by which high grade serous carcinoma ...

In a landmark investigation poised to reshape ovarian cancer prevention strategies, obstetrician-gynecologists (OBGYNs) in British Columbia have weighed in on ...